Health & Biotech
Creso Pharma (ASX:CPH) is a global medicinal cannabis innovator that develops cannabis and hemp-derived therapeutic, nutraceutical and lifestyle products for both people and animals.
Founded by a team of highly experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.
It was the first company to import medical cannabis to Australia and it has a presence across Canada, under its subsidiary Mernova, Switzerland and the EU, Israel, Latin America and Australia.
From the outset, Creso’s goal has been to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
Creso can deliver products with standardised dosing and formulations through the application of pharmaceutical rigour, Good Manufacturing Practices (GMP) standards when appropriate and proprietary, innovative delivery technologies.
As a global company, Creso is not limited by any single market. This enables Creso to offer a diverse portfolio of solutions to the widest possible population.
By partnering with leading global companies in critical areas of research and product development, manufacturing and distribution, Creso has been able to accelerate the development and distribution of approved products allowing for broad access by patients and consumers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
Creso Pharma completes acquisition of Canada-based Halucenex, set to enter the US$100 billion psychedelic market
Health & Biotech
Creso Pharma expands global footprint to Netherlands with maiden sale of Red Light Holland
Health & Biotech
Creso Pharma delivers another strong quarter as Connecticut brings a new market opportunity
Health & Biotech
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry
Health & Biotech
‘Massive’ opportunity in psychedelic-based therapy, expert says
Health & Biotech
Creso Pharma is Canada-bound after announcing a merger with Red Light Holland
Health & Biotech
Weed Week: Amazon all-in on marijuana; free joints for jabs and Creso Pharma dual-listed in US
Health & Biotech
Creso Pharma US shares surge on dual-listing
Health & Biotech
Creso Pharma secures direct access to the world’s biggest cannabis market with successful US dual-listing
Health & Biotech
Creso Pharma’s takeover target expands scope of PTSD ‘shroom’ trial beyond military vets
Health & Biotech
Creso Pharma sells hemp products in Ecuador, gears up for the lucrative Latin American market
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Weed Week: Major shifts in US legislation set to open the door for some ASX cannabis stocks
News
Closing Bell: Today’s biggest small cap movers on the ASX
Health & Biotech
Creso Pharma about to enter California market after major legislation shift on psychedelics
Health & Biotech
Cannabis sector boosted by MORE progress with US Congress
Health & Biotech